Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S46] Establishing Real-World-Evidence in Japan, from the Perspective of Database Utilization

Session Chair(s)

Koji  Kawakami, MD, PhD

Koji Kawakami, MD, PhD

Professor and Chair, Department of Pharmacoepidemiology

Graduate School of Medicine and Public Health, Kyoto University, Japan

Real-world-evidence(RWE) has become more important, in association with increasing recognition of value-based-medicine or healthcare. In Japan, the healthcare industry, government and academia are making great efforts to establish various databases or patient registries to be utilized for clinical development, pharmacovigilance or research purpose. However, RWE in Japan is still very much behind compared with those of western countries. The purpose of this session is to discuss how to promote RWE generation in Japan, especially from the perspective of utilization of database. The overviews of RWE in Japan or other countries will be provided. Also, the speaker from Japanese pharmaceutical industry will share recent experience of RWE generation.


Koji  Kawakami, MD, PhD

The Largest Clinical RWD Database Development in Japan - Overview and Future Opportunities

Koji Kawakami, MD, PhD

Graduate School of Medicine and Public Health, Kyoto University, Japan

Professor and Chair, Department of Pharmacoepidemiology

Eiko  Shimizu, PhD, MSc

RWD frontline: Expectation for RWD and its limitation in Japan

Eiko Shimizu, PhD, MSc

The University of Tokyo, Japan

Project Lecturer, Pharmaco-Business Innovation, Graduate School of Phama Science

Toshinaga  Tsuji, PhD

Work Productivity and Disease Burden in Patients with Pain Using Japanese Web Survey

Toshinaga Tsuji, PhD

Shionogi & Co., Ltd, Japan

Scientific Leader (CNS), Medical Affairs

Nancy A Dreyer, PhD, MPH, FISPE

Growing Regulatory Use of RWE Outside of Japan

Nancy A Dreyer, PhD, MPH, FISPE

Dreyer Strategies LLC, United States


Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.